Comparative effects of three carcinogens on human, rat and mouse hepatocytes. 1989

K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
Department of Pathology, University of Maryland, School of Medicine, Baltimore.

Ultrastructural changes commonly observed in liver cells of rodents exposed to carcinogens in vivo can be induced in hepatocytes exposed to carcinogens in vitro. Human, rat and mouse hepatocytes in primary culture were treated with actinomycin D, aflatoxin B1 (AFB1) and dimethylnitrosamine (DMN). These cultured hepatocytes were examined for ultrastructural alterations following carcinogen exposure for 24 h. Similar to the effects on liver cells in vivo, the most prominent change was a segregation of the nucleolar components. Human, rat and mouse hepatocytes, dosed with 7.9 X 10(-8) M actinomycin D, developed nucleolar segregation in 86%, 98% and 55% of cells, respectively. When incubated with 3.2 X 10(-6) M AFB1, 60% of human and 84% of rat hepatocytes developed nucleolar segregation. However, exposures of mouse hepatocytes less than or equal to 3.2 X 10(-5) M of AFB1 failed to induce segregation of the nucleolus. DMN administered at a dose of 2.0 X 10(-2) M caused segregation in 11% of the rat hepatocytes and in 60% of the mouse hepatocytes. Distinct nucleolar segregation did not occur in human hepatocytes until they were exposed to a concentration of 5.0 X 10(-2) M DMN (31%). Actinomycin D, AFB1, DMN, as well as other compounds that bind to DNA and interfere with template activity cause nucleolar segregation. Morphologic changes observed in cultured rat and mouse hepatocytes correlate well with in vivo experiments with regard to the relative sensitivity of rats and mice to toxicological effects of these carcinogens. Thus, hepatocyte cultures may provide a realistic system to determine the sensitivity of human liver cells to carcinogens.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002466 Cell Nucleolus Within most types of eukaryotic CELL NUCLEUS, a distinct region, not delimited by a membrane, in which some species of rRNA (RNA, RIBOSOMAL) are synthesized and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rRNA is transcribed from a nucleolar organizer, i.e., a group of tandemly repeated chromosomal genes which encode rRNA and which are transcribed by RNA polymerase I. (Singleton & Sainsbury, Dictionary of Microbiology & Molecular Biology, 2d ed) Plasmosome,Cell Nucleoli,Nucleoli, Cell,Nucleolus, Cell,Plasmosomes
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004128 Dimethylnitrosamine A nitrosamine derivative with alkylating, carcinogenic, and mutagenic properties. It causes serious liver damage and is a hepatocarcinogen in rodents. Nitrosodimethylamine,N-Nitrosodimethylamine,NDMA Nitrosodimethylamine,N Nitrosodimethylamine,Nitrosodimethylamine, NDMA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000348 Aflatoxins Furano-furano-benzopyrans that are produced by ASPERGILLUS from STERIGMATOCYSTIN. They are structurally related to COUMARINS and easily oxidized to an epoxide form to become ALKYLATING AGENTS. Members of the group include AFLATOXIN B1; aflatoxin B2, aflatoxin G1, aflatoxin G2; AFLATOXIN M1; and aflatoxin M2. Aflatoxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016604 Aflatoxin B1 A potent hepatotoxic and hepatocarcinogenic mycotoxin produced by the Aspergillus flavus group of fungi. It is also mutagenic, teratogenic, and causes immunosuppression in animals. It is found as a contaminant in peanuts, cottonseed meal, corn, and other grains. The mycotoxin requires epoxidation to aflatoxin B1 2,3-oxide for activation. Microsomal monooxygenases biotransform the toxin to the less toxic metabolites aflatoxin M1 and Q1. Aflatoxin B(1),Aflatoxin B,Aflatoxin B1 Dihydrochloride, (6aR-cis)-Isomer,Aflatoxin B1, (6aR-cis)-Isomer, 14C-Labeled,Aflatoxin B1, (6aR-cis)-Isomer, 2H-Labeled,Aflatoxin B1, (6aR-cis)-Isomer, 3H-Labeled,Aflatoxin B1, cis(+,-)-Isomer,HSDB-3453,NSC-529592,HSDB 3453,HSDB3453,NSC 529592,NSC529592
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
March 1986, Cancer research,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
August 1979, Biochemical Society transactions,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
April 2016, Archives of pharmacal research,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
January 2024, Toxicological research,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
January 1981, Carcinogenesis,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
February 1987, Mutation research,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
June 2006, Drug metabolism and disposition: the biological fate of chemicals,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
November 1996, Drug metabolism and disposition: the biological fate of chemicals,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
October 1990, Biochemical Society transactions,
K E Cole, and T W Jones, and M M Lipsky, and B F Trump, and I C Hsu
September 1983, Carcinogenesis,
Copied contents to your clipboard!